Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients
Genome Biology(2015)
摘要
Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease, with 30% to 40% of patients failing to be cured with available primary therapy. microRNAs (miRNAs) are RNA molecules that attenuate expression of their mRNA targets. To characterize the DLBCL miRNome, we sequenced miRNAs from 92 DLBCL and 15 benign centroblast fresh frozen samples and from 140 DLBCL formalin-fixed, paraffin-embedded tissue samples for validation.
更多查看译文
关键词
Overall Survival,Gene Ontology,Validation Cohort,International Prognostic Index,miRNA Expression Profile
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要